These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 18260727

  • 1. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
    Deerasamee S, Srivatanakul P, Sriplung H, Nilvachararung S, Tansuwan U, Pitakpraiwan P, Kaewkungwal J, Singhasivanon P, Nimnakorn P, Sankaranarayanan R.
    Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
    [Abstract] [Full Text] [Related]

  • 2. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W, Chaovakiratipong C, Nguntra P, Mahasakpan P, Tatip Y, Boonmak C.
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [Abstract] [Full Text] [Related]

  • 3. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W, Chaovakiratipong C, Nguntra P, Mahasakpan P, Lerdlukanavonge P, Koonchote S.
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [Abstract] [Full Text] [Related]

  • 4. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
    Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.
    J Natl Cancer Inst; 2002 Oct 02; 94(19):1469-83. PubMed ID: 12359856
    [Abstract] [Full Text] [Related]

  • 5. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.
    Praditsitthikorn N, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V.
    Pharmacoeconomics; 2011 Sep 02; 29(9):781-806. PubMed ID: 21838332
    [Abstract] [Full Text] [Related]

  • 6. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
    Liao SY, Stanbridge EJ.
    Cancer; 2000 Mar 01; 88(5):1108-21. PubMed ID: 10699902
    [Abstract] [Full Text] [Related]

  • 7. Organization and evolution of organized cervical cytology screening in Thailand.
    Khuhaprema T, Attasara P, Srivatanakul P, Sangrajrang S, Muwonge R, Sauvaget C, Sankaranarayanan R.
    Int J Gynaecol Obstet; 2012 Aug 01; 118(2):107-11. PubMed ID: 22613493
    [Abstract] [Full Text] [Related]

  • 8. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
    Luyten A, Scherbring S, Reinecke-Lüthge A, Braun BE, Pietralla M, Theiler K, Petry KU.
    J Clin Virol; 2009 Nov 01; 46 Suppl 3():S5-10. PubMed ID: 20129072
    [Abstract] [Full Text] [Related]

  • 9. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.
    Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, van Ballegooijen M, Meijer CJ.
    Int J Cancer; 1996 Dec 11; 68(6):766-9. PubMed ID: 8980181
    [Abstract] [Full Text] [Related]

  • 10. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr 11; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 11. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.
    Strander B, Andersson-Ellström A, Milsom I, Rådberg T, Ryd W.
    Cancer; 2007 Oct 25; 111(5):285-91. PubMed ID: 17724676
    [Abstract] [Full Text] [Related]

  • 12. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A.
    JAMA; 2000 Jan 05; 283(1):81-6. PubMed ID: 10632284
    [Abstract] [Full Text] [Related]

  • 13. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P, Moresco L, Giorgi Rossi P.
    Epidemiol Prev; 2012 Jan 05; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [Abstract] [Full Text] [Related]

  • 14. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF, Skare GB, Thoresen SØ.
    J Med Screen; 2002 Jan 05; 9(2):86-91. PubMed ID: 12133929
    [Abstract] [Full Text] [Related]

  • 15. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G, Biggeri A, Confortini M, Naldoni C, Segnan N, Sideri M, Zappa M, Zorzi M, Calvia M, Accetta G, Giordano L, Cogo C, Carozzi F, Gillio Tos A, Arbyn M, Mejier CJ, Snijders PJ, Cuzick J, Giorgi Rossi P.
    Epidemiol Prev; 2012 Jan 05; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [Abstract] [Full Text] [Related]

  • 16. Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.
    Sriplung H, Singkham P, Iamsirithaworn S, Jiraphongsa C, Bilheem S.
    Asian Pac J Cancer Prev; 2014 Jan 05; 15(22):10003-8. PubMed ID: 25520060
    [Abstract] [Full Text] [Related]

  • 17. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ.
    JAMA; 2018 Jul 03; 320(1):43-52. PubMed ID: 29971397
    [Abstract] [Full Text] [Related]

  • 18. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.
    J Natl Cancer Inst; 2009 Dec 02; 101(23):1612-23. PubMed ID: 19903804
    [Abstract] [Full Text] [Related]

  • 19. Positive diagnostic values and histological detection ratios from the Rotterdam cervical cancer screening programme.
    Kreuger FA, Beerman H, Nijs HG, van Ballegooijen M.
    Int J Epidemiol; 1998 Jun 02; 27(3):377-81. PubMed ID: 9698123
    [Abstract] [Full Text] [Related]

  • 20. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S, Steinberg W, Schneider W, Hanrath C.
    J Clin Virol; 2009 Nov 02; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.